๐ŸŽ—๏ธ OncologyInjection (IV)

    Lynozyfic

    Linvoseltamab

    BCMA-directed bispecific antibody for relapsed/refractory multiple myeloma after at least 4 prior lines of therapy.

    Form

    Injection (IV)

    Uses

    1

    Side effects

    5

    Category

    Oncology

    01

    What is Lynozyfic used for?

    • Relapsed/refractory multiple myeloma
    02

    Linvoseltamab side effects

    The following side effects have been reported for Linvoseltamab. Their order does not indicate how often an effect occurs.

    Cytokine release syndrome
    Infections
    Neutropenia
    Anemia
    Neurotoxicity
    03

    Linvoseltamab warnings & precautions

    • Black box: CRS and ICANS. Step-up dosing and REMS required
    • Serious infections possible

    Loading FDA dataโ€ฆ

    04

    Frequently asked questions

    05

    Related medications

    Share

    Share this drug info.

    Help friends and family understand Lynozyfic in plain language.

    Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.